
Israel's parliament on Monday approved a controversial bill to reintroduce the death penalty for terrorists, a move considered racist by critics as the legislation would effectively only apply to Palestinians.
Rights organizations and several European countries had called for the initiative to be stopped.
Under the bill, Palestinians convicted of murder as an act of terrorism by military courts in the occupied territories would face a mandatory death sentence.
In civilian courts in Israel, meanwhile, a person convicted of murder with a terrorism motive with the aim of destroying the State of Israel could be sentenced either to death or to life imprisonment under the law.
The bill was introduced by the Otzma Yehudit party of far-right Minister of National Security Itamar Ben-Gvir.
A total of 62 of 120 lawmakers in the Knesset backed the bill in a final vote on Monday, including Prime Minister Benjamin Netanyahu. A total of 48 lawmakers voted against the bill, while the rest abstained or were not present for the vote.
latest_posts
- 1
Four new luxury hotel openings in Italy you need to know about - 2
Clocks to go forward one hour in Europe as summer time starts - 3
The Best Internet based Courses for Expertise Improvement - 4
These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going. - 5
Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
Golden satellite insulation sparkles during test | Space photo of the day for Dec. 30, 2025
Discovery off Israel’s coast reveals earliest known 2,600-year-old shipment of raw iron
Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone'
Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
5 Must-Attempt Fascinating Dishes from Around the World
Why haven’t humans been back to the moon in over 50 years?
This cafe takes orders in sign language. It's cherished by the Deaf community
Find the Specialty of Public Speaking: Drawing in and Convincing Crowds with Certainty
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials













